Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $100
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $104 to $100.
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $104 to $100.